Mar 16, 2022 / 03:00PM GMT
Ami Fadia - Needham & Company - Analyst
Good morning, everyone, again. Welcome to the next session with Karuna. I have the pleasure of hosting Andrew Miller who is the Founder and COO of the company. As you know, Dr. Miller is the lead inventor of Karuna's KarXT platform and he also served as the CEO of the company prior to his current role.
With that, Andrew, thank you so much for taking the time to be with us here today. If you could kick us off with some brief comments and then we'll jump right into questions. Just a quick reminder for the audience, if you have any questions that you want me to ask Andrew, please feel free to send it over the chat. Andrew, with that over to you.
Andrew Miller - Karuna Therapeutics, Inc. - Founder & COO
Great, thank you and really appreciate the time and opportunity to talk about what we're doing at Karuna, so looking forward to that and appreciate it. In terms of just maybe some brief introductory comments, our focus at Karuna is in developing innovative treatments for serious mental illness. Particularly you
Karuna Therapeutics Inc at Needham Neuroscience Forum (Virtual) Transcript
Mar 16, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers